{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:41:39Z","timestamp":1777614099307,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12020-018-1664-7","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T05:55:06Z","timestamp":1531806906000},"page":"518-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Lack of functional remission in Cushing\u2019s syndrome"],"prefix":"10.1007","volume":"61","author":[{"given":"M.","family":"Vermalle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alessandrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Graillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C","family":"Paladino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Baumstarck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Brue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-8800","authenticated-orcid":false,"given":"F.","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"issue":"2","key":"1664_CR1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","volume":"18","author":"ST Sharma","year":"2015","unstructured":"S.T. Sharma, L.K. Nieman, R.A. Feelders, Comorbidities in Cushing\u2019s disease. Pituitary 18(2), 188\u2013194 (2015)","journal-title":"Pituitary"},{"issue":"3","key":"1664_CR2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/jc.2012-2893","volume":"98","author":"JK Lambert","year":"2013","unstructured":"J.K. Lambert, L. Goldberg, S. Fayngold, J. Kostadinov, K.D. Post, E.B. Geer, Predictors of mortality and long-term outcomes in treated Cushing\u2019s disease: a study of 346 patients. J. Clin. Endocrinol. Metab. 98(3), 1022\u20131030 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1664_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0516-x","volume":"11","author":"T Brue","year":"2016","unstructured":"T. Brue, F. Castinetti, The risks of overlooking the diagnosis of secreting pituitary adenomas. Orphanet. J. Rare. Dis. 11(1), 135 (2016)","journal-title":"Orphanet. J. Rare. Dis."},{"issue":"3","key":"1664_CR4","first-page":"912","volume":"82","author":"LD Dorn","year":"1997","unstructured":"L.D. Dorn, E.S. Burgess, T.C. Friedman, B. Dubbert, P.W. Gold, G.P. Chrousos, The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 82(3), 912\u2013919 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1664_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"O.M. Dekkers, E. Horvath-Puho, J.O. Jorgensen, S.C. Cannegieter, V. Ehrenstein, J.P. Vandenbroucke et al.Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study. J. Clin. Endocrinol. Metab. 98(6), 2277\u20132284 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"1664_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-13-0555","volume":"171","author":"M Terzolo","year":"2014","unstructured":"M. Terzolo, B. Allasino, A. Pia, G. Peraga, F. Daffara, F. Laino et al.Surgical remission of Cushing\u2019s syndrome reduces cardiovascular risk. Eur. J. Endocrinol. 171(1), 127\u2013136 (2014)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1664_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ecl.2005.01.010","volume":"34","author":"R Pivonello","year":"2005","unstructured":"R. Pivonello, A. Faggiano, G. Lombardi, A. Colao, The metabolic syndrome and cardiovascular risk in Cushing\u2019s syndrome. Endocrinol. Metab. Clin. North. Am. 34(2), 327\u2013339 (2005). viii","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"8","key":"1664_CR8","first-page":"2664","volume":"84","author":"A Colao","year":"1999","unstructured":"A. Colao, R. Pivonello, S. Spiezia, A. Faggiano, D. Ferone, M. Filippella et al.Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J. Clin. Endocrinol. Metab. 84(8), 2664\u20132672 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"1664_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000314317","volume":"92","author":"AM Pereira","year":"2010","unstructured":"A.M. Pereira, J. Tiemensma, J.A. Romijn, Neuropsychiatric disorders in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1), 65\u201370 (2010)","journal-title":"Neuroendocrinology"},{"issue":"5","key":"1664_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-12-0308","volume":"167","author":"MA Wagenmakers","year":"2012","unstructured":"M.A. Wagenmakers, R.T. Netea-Maier, J.B. Prins, T. Dekkers, M. den Heijer, A.R. Hermus, Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur. J. Endocrinol. 167(5), 687\u2013695 (2012)","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"1664_CR11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1530\/EJE-11-0307","volume":"165","author":"J Tiemensma","year":"2011","unstructured":"J. Tiemensma, A.A. Kaptein, A.M. Pereira, J.W. Smit, J.A. Romijn, N.R. Biermasz, Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing\u2019s syndrome. Eur. J. Endocrinol. 165(4), 527\u2013535 (2011)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1664_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1017\/S0033291798006667","volume":"28","author":"Development of the World Health Organization WHOQOL-BREF quality of life assessment","year":"1998","unstructured":"Development of the World Health Organization WHOQOL-BREF quality of life assessment, The WHOQOL Group. Psychol. Med. 28(3), 551\u2013558 (1998)","journal-title":"Psychol. Med."},{"issue":"1","key":"1664_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.respe.2009.10.009","volume":"58","author":"C Baumann","year":"2010","unstructured":"C. Baumann, M.L. Erpelding, S. Regat, J.F. Collin, S. Briancon, The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions. Rev. Epidemiol. Sante Publique 58(1), 33\u201339 (2010)","journal-title":"Rev. Epidemiol. Sante Publique"},{"issue":"5","key":"1664_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"S.M. Webb, X. Badia, M.J. Barahona, A. Colao, C.J. Strasburger, A. Tabarin et al.Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire. Eur. J. Endocrinol. 158(5), 623\u2013630 (2008)","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"1664_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"A.S. Zigmond, R.P. Snaith, The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67(6), 361\u2013370 (1983)","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"1664_CR16","first-page":"175","volume":"143","author":"JP Lepine","year":"1985","unstructured":"J.P. Lepine, M. Godchau, P. Brun, T. Lemperiere, [Evaluation of anxiety and depression among patients hospitalized on an internal medicine service]. Ann. Med. Psychol. (Paris) 143(2), 175\u2013189 (1985)","journal-title":"Ann. Med. Psychol. (Paris)"},{"key":"1664_CR17","doi-asserted-by":"crossref","unstructured":"Rosenberg M. Society and the Adolescent Self-Image. Princeton: Princeton University Press. 1965.","DOI":"10.1515\/9781400876136"},{"issue":"2","key":"1664_CR18","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/00207599008247865","volume":"25","author":"E Vallieres","year":"1990","unstructured":"E. Vallieres, R. Vallerand, Traduction et Validation Canadienne-Fran\u00e7aise de L\u2019\u00e9chelle de L\u2019estime de Soi de Rosenberg. Int. J. Psychol. 25(2), 305\u2013316 (1990)","journal-title":"Int. J. Psychol."},{"issue":"1","key":"1664_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2466\/pms.2002.94.1.189","volume":"94","author":"M Koleck","year":"2002","unstructured":"M. Koleck, M. Bruchon-Schweitzer, F. Cousson-Gelie, J. Gilliard, B. Quintard, The body-image questionnaire: an extension. Percept. Mot. Skills 94(1), 189\u2013196 (2002)","journal-title":"Percept. Mot. Skills"},{"key":"1664_CR20","unstructured":"Lazarus R., Folkman S. Stress, appraisal, and coping: New York: Springer; 1984."},{"issue":"6","key":"1664_CR21","first-page":"507","volume":"29","author":"L Muller","year":"2003","unstructured":"L. Muller, E. Spitz, [Multidimensional assessment of coping: validation of the Brief COPE among French population]. Encephale 29(6), 507\u2013518 (2003)","journal-title":"Encephale"},{"issue":"1","key":"1664_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12955-016-0581-9","volume":"15","author":"K Baumstarck","year":"2017","unstructured":"K. Baumstarck, M. Alessandrini, Z. Hamidou, P. Auquier, T. Leroy, L. Boyer, Assessment of coping: a new french four-factor structure of the brief COPE inventory. Health Qual. Life Outcomes 15(1), 8 (2017)","journal-title":"Health Qual. Life Outcomes"},{"issue":"3","key":"1664_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11102-017-0793-y","volume":"20","author":"P Pires","year":"2017","unstructured":"P. Pires, A. Santos, Y. Vives-Gilabert, S.M. Webb, A. Sainz-Ruiz, E. Resmini et al. White matter involvement on DTI-MRI in Cushing\u2019s syndrome relates to mood disturbances and processing speed: a case-control study. Pituitary 20(3), 340\u2013348 (2017)","journal-title":"Pituitary"},{"issue":"2","key":"1664_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1176\/appi.ajp.157.2.220","volume":"157","author":"M Tohen","year":"2000","unstructured":"M. Tohen, J. Hennen, C.M. Zarate Jr., R.J. Baldessarini, S.M. Strakowski, A.L. Stoll et al. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am. J. Psychiatry 157(2), 220\u2013228 (2000)","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"1664_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40265-017-0735-z","volume":"77","author":"A Santos","year":"2017","unstructured":"A. Santos, E. Resmini, J.C. Pascual, I. Crespo, S.M. Webb, Psychiatric symptoms in patients with Cushing\u2019s syndrome: prevalence, diagnosis and management. Drugs 77(8), 829\u2013842 (2017)","journal-title":"Drugs"},{"issue":"2","key":"1664_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40271-013-0012-5","volume":"6","author":"LM Nelson","year":"2013","unstructured":"L.M. Nelson, A. Forsythe, L. McLeod, S. Pulgar, M. Maldonado, T. Coles et al. Psychometric evaluation of the Cushing\u2019s Quality-of-Life questionnaire. Patient 6(2), 113\u2013124 (2013)","journal-title":"Patient"},{"issue":"5","key":"1664_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1176\/appi.psy.45.5.438","volume":"45","author":"KA Phillips","year":"2004","unstructured":"K.A. Phillips, S.A. Rasmussen, Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics 45(5), 438\u2013444 (2004)","journal-title":"Psychosomatics"},{"issue":"3","key":"1664_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000147454","volume":"26","author":"S Choi-Kwon","year":"2008","unstructured":"S. Choi-Kwon, J. Choi, S.U. Kwon, D.W. Kang, J.S. Kim, Fluoxetine improves the quality of life in patients with poststroke emotional disturbances. Cerebrovasc. Dis. 26(3), 266\u2013271 (2008)","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"1664_CR29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.eurpsy.2010.09.003","volume":"26","author":"T Toffanin","year":"2011","unstructured":"T. Toffanin, F. Nifosi, H. Follador, A. Passamani, F. Zonta, G. Ferri et al. Volumetric MRI analysis of hippocampal subregions in Cushing\u2019s disease: a model for glucocorticoid neural modulation. Eur. Psychiatry 26(1), 64\u201367 (2011)","journal-title":"Eur. Psychiatry"},{"issue":"5","key":"1664_CR30","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/cen.12224","volume":"79","author":"E Resmini","year":"2013","unstructured":"E. Resmini, A. Santos, B. Gomez-Anson, O. Lopez-Mourelo, P. Pires, Y. Vives-Gilabert et al. Hippocampal dysfunction in cured Cushing\u2019s syndrome patients, detected by (1) H-MR-spectroscopy. Clin. Endocrinol. (Oxf.). 79(5), 700\u2013707 (2013)","journal-title":"Clin. Endocrinol. (Oxf.)."},{"key":"1664_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.54","volume":"1","author":"JM Launay","year":"2011","unstructured":"J.M. Launay, S. Mouillet-Richard, A. Baudry, M. Pietri, O. Kellermann, Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl. Psychiatry 1, e56 (2011)","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"1664_CR32","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1210\/jc.2012-1235","volume":"97","author":"J Tiemensma","year":"2012","unstructured":"J. Tiemensma, N.P. Daskalakis, E.M. van der Veen, S. Ramondt, S.K. Richardson, E. Broadbent et al. Drawings reflect a new dimension of the psychological impact of long-term remission of Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 97(9), 3123\u20133131 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1664_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/EJE-12-1078","volume":"168","author":"SB Abraham","year":"2013","unstructured":"S.B. Abraham, B.S. Abel, D. Rubino, T. Nansel, S. Ramsey, L.K. Nieman, A direct comparison of quality of life in obese and Cushing\u2019s syndrome patients. Eur. J. Endocrinol. 168(5), 787\u2013793 (2013)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1664_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11102-015-0690-1","volume":"19","author":"EB Geer","year":"2016","unstructured":"E.B. Geer, Y. Lalazar, L.M. Couto, V. Cohen, L.R. Lipton, W. Shi et al. A prospective study of appetite and food craving in 30 patients with Cushing\u2019s disease. Pituitary 19(2), 117\u2013126 (2016)","journal-title":"Pituitary"},{"issue":"1","key":"1664_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-17-0048","volume":"177","author":"C Bucy De","year":"2017","unstructured":"C. De Bucy, L. Guignat, T. Niati, J. Bertherat, J. Coste, Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study. Eur. J. Endocrinol. 177(1), 1\u20138 (2017)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1664_CR36","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1530\/EJE-15-1242","volume":"175","author":"S Bensing","year":"2016","unstructured":"S. Bensing, A.L. Hulting, E.S. Husebye, O. Kampe, K. Lovas, MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, quality of life and complications of primary adrenal insufficiency: a review. Eur. J. Endocrinol. 175(3), R107\u2013R116 (2016)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1664_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/EJE-14-0023","volume":"171","author":"J Tiemensma","year":"2014","unstructured":"J. Tiemensma, C.D. Andela, A.A. Kaptein, J.A. Romijn, R.C. van der Mast, N.R. Biermasz et al. Psychological morbidity and impaired quality of life in patients with stable treatment for primary adrenal insufficiency: cross-sectional study and review of the literature. Eur. J. Endocrinol. 171(2), 171\u2013182 (2014)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"1664_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1207\/S15324826AN1003_04","volume":"10","author":"SR Kesler","year":"2003","unstructured":"S.R. Kesler, H.F. Adams, C.M. Blasey, E.D. Bigler, Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis. Appl. Neuropsychol. 10(3), 153\u2013162 (2003)","journal-title":"Appl. Neuropsychol."},{"issue":"11","key":"1664_CR39","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Y. Stern, Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 11(11), 1006\u20131012 (2012)","journal-title":"Lancet Neurol."},{"issue":"5","key":"1664_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1076\/jcen.25.5.589.14571","volume":"25","author":"Y Stern","year":"2003","unstructured":"Y. Stern, The concept of cognitive reserve: a catalyst for research. J. Clin. Exp. Neuropsychol. 25(5), 589\u2013593 (2003)","journal-title":"J. Clin. Exp. Neuropsychol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T09:09:28Z","timestamp":1720429768000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1664-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,17]]},"assertion":[{"value":"24 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MV, MA, TG, CP, KB, FS, HD, TB, and FC declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}